The prognostic value of tissue inhibitor of metalloproteinases-1 (TIMP-1) in metastatic colorectal cancer treated with third-line cetuximab-irinotecan

被引：0
|
作者：
Spindler, K. [1 ]
Nielsen, H. J. [2 ]
Brunner, N. [3 ]
Jakobsen, A. [4 ]
机构：
[1] Vejle Hosp, Dept Oncol, Vejle, Denmark
[2] Univ Copenhagen, Hvidovre Hosp, Dept Surg Gastroenterol, DK-2650 Hvidovre, Denmark
[3] Univ Copenhagen, Inst Vet Pathobiol, Fac Life Sci, Frederiksberg, Denmark
[4] Univ So Denmark, Vejle Hosp, Vejle, Denmark
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：358 / 358
页数：1
相关论文
共 50 条
  • [1] TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuximab for metastatic colorectal cancer
    Spindler, Karen-Lise Garm
    Christensen, Ib Jarle
    Nielsen, Hans Jorgen
    Jakobsen, Anders
    Bruenner, Nils
    TUMOR BIOLOGY, 2015, 36 (06) : 4301 - 4308
  • [2] Tissue inhibitor of metalloproteinases-1 (TIMP-1) as tumor marker in colorectal cancer
    Nanna, Sorensen M.
    Blincko, S.
    Weerakoon, A.
    Dinsmore, E. J.
    Lally, J. P.
    Rogers, B. C.
    Christensen, I. J.
    Jensen, V
    Bruenner, N.
    Nielsen, H. J.
    Dowel, B.
    Davis, G.
    TUMOR BIOLOGY, 2006, 27 : 38 - 38
  • [3] Independent prognostic value of plasma tissue inhibitor of metalloproteinases-1 (TIMP-1) in colorectal cancer: A prospective validation study
    Nielsen, H. J.
    Ghanipour, A.
    Christensen, I. J.
    Glimelius, B.
    Brunner, N.
    Birgisson, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Serum levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) in colorectal cancer patients
    Ishida, H
    Murata, N
    Hayashi, Y
    Tada, M
    Hashimoto, D
    SURGERY TODAY, 2003, 33 (12) : 885 - 892
  • [5] Serum Levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) in Colorectal Cancer Patients
    Hideyuki Ishida
    Nobuo Murata
    Yoichi Hayashi
    Masakazu Tada
    Daijo Hashimoto
    Surgery Today, 2003, 33 : 885 - 892
  • [6] FUNCTIONAL DOMAINS IN THE TISSUE INHIBITOR OF METALLOPROTEINASES-1 (TIMP-1)
    CATERINA, NCM
    WINDSOR, LJ
    TAYLOR, KB
    BIRKEDALHANSEN, H
    ENGLER, JA
    JOURNAL OF DENTAL RESEARCH, 1995, 74 : 590 - 590
  • [7] Immunohistochemical tissue inhibitor of metalloproteinases-1 (TIMP-1) score is a prognostic marker in glioblastoma
    Aaberg-Jessen, C.
    Christensen, K.
    Schroder, H. D.
    Offenberg, H.
    Brunner, N.
    Kristensen, B. W.
    APMIS, 2008, 116 (05) : 425 - 425
  • [8] EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer
    Karen-Lise G Spindler
    Niels Pallisgaard
    Jan Lindebjerg
    Sanne K Frifeldt
    Anders Jakobsen
    BMC Cancer, 11
  • [9] EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer
    Spindler, Karen-Lise G.
    Pallisgaard, Niels
    Lindebjerg, Jan
    Frifeldt, Sanne K.
    Jakobsen, Anders
    BMC CANCER, 2011, 11
  • [10] Inactivation of tissue inhibitor of metalloproteinases-1 (TIMP-1) by Porphyromonas gingivalis
    Grenier, D
    Mayrand, D
    FEMS MICROBIOLOGY LETTERS, 2001, 203 (02) : 161 - 164
12345